Robert A. Baughman
12Patents
3h-index
9Co-inventors
49Inventor score
Filing activity: Oct 24, 2008 → Aug 3, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8119593B2 | Method of treating diabetes type 2 by metformin and an ultrarapid acting insulin | Human Necessities | 102 | Active |
| US8372804B2 | Delivery of active agents | Human Necessities | 58 | Active |
| US8377869B2 | Method of preventing adverse effects by GLP-1 | Human Necessities | 55 | Active |
| US11110151B2 | Composition and method for reducing hypoglycemia events in diabetes treatment | Human Necessities | 1 | Active |
| US11998591B2 | Method of treating diabetes type 2 by administering ultrarapid acting insulin | Human Necessities | 0 | Active |
| US10857207B2 | Method of treating diabetes type 2 by administering ultrarapid acting insulin | Human Necessities | 0 | Active |
| US9943571B2 | Use of ultrarapid acting insulin | Human Necessities | 0 | Active |
| US9078866B2 | Method for treating hyperglycemia with GLP-1 | Human Necessities | 0 | Active |
| US11304992B2 | Inhalable dry powder pharmaceutical composition | Human Necessities | 0 | Active |
| US8921311B2 | Method for treating hyperglycemia | Human Necessities | 0 | Active |
| US8623817B2 | Method of treating diabetes type 2 by administering ultrarapid acting insulin | Human Necessities | 0 | Active |
| US11980656B2 | Method of treating hypoglycemia events in diabetes treatment | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.